TheEdgeResearch
Home / Stocks / BDPT

BioAdaptives Inc. (BDPT)

OTC Healthcare Medical - Pharmaceuticals
$0.00 ▼ -4.00%
Market Cap
$236,312
Sector
Healthcare
Industry
Medical - Pharmaceuticals
Beta
1.19
52-Wk Range
0.0008-0.0335
CEO
James Keener
Country
US
Currency
USD

BioAdaptives Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Las Vegas, NV, US. The stock last traded at $0.00, down 4.00% on the session, giving a market capitalisation of $236,312. On trailing twelve-month figures it carries a trailing P/E of -0.01, a net margin of -8806.4%. Its beta of 1.19 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.01
Price / Sales
9.12
Price / Book
-0.08
EV / EBITDA
-0.60
Gross margin
71.2%
Operating margin
-3610.9%
Net margin
-8806.4%
Return on equity
—
Debt / equity
-0.21
Current ratio
0.02
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
1
IPO date
2016-06-01
Headquarters
Las Vegas, NV, US
About BioAdaptives Inc.

BioAdaptives, Inc. is a research and development company that develops and markets nutraceutical and dietary supplement products for humans and animals. Its products are derived from natural plant, fungi, and algal-based sources and include supplements for cognitive enhancement, weight management, and regenerative wellness.

Comparable companies

BioAdaptives Inc. is most often compared with the following Healthcare names:

AJYGBSFCDEWMDMANHSEEFKOMOFMYLKFQEDNRTONVPRIF
More research on BDPT
BDPT technical analysis BDPT TheEdge Score Compare against peers
Open full interactive analysis & DCF →